News | Atrial Fibrillation | August 23, 2023

New Device Helps Prevent Complication During Common Heart Procedure

By gently diverting the esophagus, heart ablations will be safer 

By gently diverting the esophagus, heart ablations will be safer

Emile Daoud, MD, helped develop a new surgical device at The Ohio State University Wexner Medical Center to prevent a common and serious complication during heart ablation procedures. The device gently moves the nearby esophagus away from the heart to prevent the ablation energy from causing damage. Image courtesy of The Ohio State University Wexner Medical Center 

 


August 23, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans and greatly increasing their risk of stroke and heart failure. For some with AFib, a catheter ablation is used to burn or freeze the precise area causing the problem to restore a normal heart rhythm. While this method is effective in treating AFib, the energy from the catheter tip can cause serious damage to the adjacent esophagus, which is only a few millimeters away. It’s an injury that can be life threatening, so an electrophysiologist at The Ohio State University Wexner Medical Center helped develop a new device that gently diverts the esophagus out of harm’s way, greatly improving safety.  

“On one hand, we want to deliver high energy and spend a lot of time ablating a specific spot to get a good, deep lesion. But on the other hand, we are very cognizant of where the esophagus is and want to do everything possible to avoid damaging that structure,” said Emile Daoud, MD, electrophysiologist and clinical professor of internal medicine at the medical center. “By pulling in the esophagus using suction force and then moving the entire segment to the side by about an inch, we are able to create a safe pathway to deliver the energy to treat AFib.” 

A clinical trial led by Ohio State found that without the device, over a third of heart ablation patients had esophageal injuries, but when the new device was used, less than 5% of patients had any injury to the esophagus, and they were much less severe than the control group. 

“There have been attempts to protect the esophagus during heart ablations in the past using different techniques like measuring the temperature inside the esophagus, using ultrasound imaging to identify where it’s located and using shorter or less intense ablation energy, but esophageal injury continued to be a serious problem,” said Daoud. “With this device, patients can rest assured that they are getting the safest procedure possible without compromising any benefits to their heart.” 

For more information: https://wexnermedical.osu.edu/ 


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now